Cardiac Dimensions® Announces Three Major Publications Demonstrating Long-Term Durability, Real-World Performance, and Broad Patient Benefit of the Carillon Mitral Contour ...

Cardiac Dimensions, a leader in transcatheter therapies for heart failure, today announced the publication of three major manuscripts that together form the most comprehensive evidence base ever ...
MassDevice

Cardiac Dimensions data highlights durability, performance of mitral annuloplasty device

Cardiac Dimensions announced today that it published three manuscripts providing new evidence supporting its Carillon mitral ...
GeekWire

Cardiac Dimensions raises $35M for device to treat condition associated with heart failure

Cardiac Dimensions, a medical device company based in Kirkland, Wash., landed $35 million to support testing and marketing of its system to treat mitral valve regurgitation. Mitral valve regurgitation ...
Business Wire

Cardiac Dimensions Raises $53 Million Series E Financing

KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions ®, a leader in minimally invasive treatments for heart failure and functional mitral regurgitation (FMR), today announced the close of an ...
GeekWire

Cardiac Dimensions lands $53M to fund research and expansion of heart valve technology

Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million from investors. Its total funding is more than $200 million. Cardiac ...
Business Wire

Cardiac Dimensions Raises $35 Million in Series D Financing

Funds Expected to Support Enrollment in U.S. Pivotal EMPOWER Trial and European Commercial Expansion for Carillon Mitral Contour System® KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions®, a leader ...
Becker's ASC

Cardiac Dimensions names chief medical officer

Satya Shreenivas, MD, has been appointed chief medical officer of Cardiac Dimensions, a medical equipment manufacturing company focusing on minimally invasive treatment options for patients who have ...